Prof Mark Little
Trinity College Dublin, Tallaght Hospital and Beaumont Hospital
After graduating from medicine in Trinity College Dublin he completed his Nephrology training in North London in 2006. During this time, he obtained a PhD from Imperial College London, and post-doctoral time spent at Hammersmith Hospital, University of Birmingham and University College London consolidated a translational research programme focused on autoimmunity and systemic vasculitis. His research interests include novel model systems for investigating the pathogenesis of ANCA vasculitis, biomarker development and application of data science techniques to study autoimmunity. He has published over 100 peer-reviewed manuscripts and was awarded the President of Ireland Young Researcher Award in 2012, when he returned to Ireland to become the Fottrell Professor of Nephrology in TCD, and consultant Nephrologist in Tallaght and Beaumont Hospitals. He is a co-founder and coordinator of ERN-RITA, the rare immune disorders European Reference Network, lead of the European Vasculitis Society Registry initiative, chair of the Vasculitis Ireland Network and co-founder/co-chair of UKIVAS, the vasculitis society of UK and Ireland.
Dr Mike Clarkson
MB, BAO BCh, University of Dublin, Trinity College
Dr Clarkson (MB, BAO BCh, University of Dublin, Trinity College 1994) undertook postgraduate training in Internal Medicine and Nephrology in Dublin 1994-2001 and was awarded an MD by thesis in 2002. He completed a clinical and research fellowship at The Brigham and Women’s Hospital and the Massachusetts General Hospital, Harvard Medical School, Boston (2001-2004). He was then appointed to the staff of the Brigham and Women’s Hospital before taking up his current position in Cork University Hospital (CUH) in 2005.
His research interests include the immunobiology of transplant rejection and small vessel vasculitis. He is a member of the Vasculitis Ireland Network and led the development of the dedicated vasculitis service at CUH.
Dr Clarkson is the recipient of a Programme Project Grant from the Health Research Board of Ireland, has authored or co-authored over 35 peer-reviewed scientific papers, 8 book chapters and is editor of the Companion Handbook to Brenner and Rector’s ‘The Kidney’.
Dr Grainne Murphy
University College Cork, Cork University Hospital
Dr Murphy graduated from University College Cork in 2003. Following specialist training in Rheumatology and General Medicine in Ireland she was awarded a fellowship in University College London in the UK where she undertook subspeciality training in systemic lupus erythematosus under the mentorship of Prof David Isenberg. She currently works as a Rheumatology Consultant in Cork University Hospital and her special interests include SLE and Vasculitis.
Ms Julie Power
Prior to diagnosis in 2005 with a rare disease called Granulomatosis with Polyangiitis Vasculitis, Julie worked for 17 years as an Occupational Therapist, specialising in Neurology and Palliative care. Following diagnosis, her life and that of her family’s was totally changed. The uncertainty and isolation Julie experienced on her patient journey has fuelled her interest in raising awareness, improving care and research. Julie believes knowledge is power and that patient involvement throughout the entire treatment and research process is mutually beneficial to the Researchers, Clinicians, Service Providers and Patients.
In 2010, she founded Vasculitis Ireland Awareness, an All Ireland support group for anyone affected by Vasculitis in Ireland, liaising closely with Vasculitis UK and the Vasculitis Foundation. Julie is a patient representative in the Irish Rare Kidney Disease Registry and Bio bank Steering Committee, the recently formed Vasculitis Ireland Network (VINE) and in planning for a pilot NI Vasculitis service. She graduated as a EUPATI (European Patient Academy in Therapeutic Intervention) fellow in 2016 after completing the 14month intensive research and development course. Julie has been a member of the Northern Ireland Rare Disease Partnership(NIRDP) board of directors since 2015, and the Irish Platform for Patient Organisations Science and Industry (IPPOSI) board of directors in 2017. She is actively involved in improving care for those affected by rare disease both in NI and ROI.
Dr. Niall Conlon
Dr. Conlon is a graduate of Queen’s University of Belfast and has a background in pharmacology. He has a PhD in Immunology from Trinity College Dublin and is a Fellow of the Royal College of Pathologists. He is Head of the Department of Clinical and Diagnostic Immunology at St. James’s Hospital. Clinical interests include Primary Immune Deficiency, Complex Allergic disorders and Chronic Urticaria, Small Vessel Vasculitis and Diagnostic Immunology.
Dr Michelle Marie O’Shaugnessy
Stanford University, Cork University Hospital
Dr. Michelle O’Shaughnessy (MB BCh BAO, MRCPI, MS, FASN) has recently returned home to Ireland from a faculty position at Stanford University, California, to take up a position as Consultant Nephrologist at Cork University Hospital. Her research focuses on glomerular disease epidemiology and clinical outcomes, including non-renal events, medication toxicity, and pregnancy outcomes. She has a Master of Science Degree in Epidemiology and Clinical Research from Stanford University, over 30 peer-reviewed publications, and is an active investigator with numerous North American glomerular disease research consortia, including the NIH-funded Nephrotic Syndrome Study Network (NEPTUNE) and CureGlomerulonephropathy (CureGN) research networks. She looks forward to establishing a world class Glomerular Disease Centre at CUH and to extending her collaborative research network to include investigators within Ireland and across Europe
Prof. Eamonn Molloy
University College Dublin
Eamonn Molloy is a medical graduate of University College Dublin, Ireland (1997) and completed rheumatology and internal medicine training in Ireland. He obtained an MD by thesis at Royal College of Surgeons of Ireland (2006), which focused on calcium crystal induced inflammation. In 2005 he commenced subspecialty fellowship training in vasculitis at the Cleveland Clinic, Ohio, USA. In 2008, he completed an MS (Clinical Research) at Case Western Reserve University and joined the consultant staff at the Vasculitis Center and RJ Fasenmeyer Center for Clinical Immunology at the Cleveland Clinic. In 2010, he was appointed as a Consultant Rheumatologist at St Vincent’s University Hospital, Dublin and is a Clinical Professor at University College Dublin School of Medicine. He is the author of over 50 publications largely pertaining to vasculitis, crystal induced arthritis and progressive multifocal leukoencephalopathy in the setting of rheumatic diseases. He has established a tertiary referral centre for vasculitis at St Vincent’s University Hospital. He has been involved in a number of clinical trials, mainly in the setting of vasculitis, as Principal Investigator and Co-Investigator. His primary translational research focus currently relates to mechanisms of vascular inflammation in Giant Cell Arteritis
Dr. Allyson Egan